Boehringer Ingelheim GmbH: Transforming the terminal cancer patient

This article describes how Boehringer Ingelheim (BI), the pharma company, wanted greater understanding of patients' sentiments when faced with life-threatening disease in the USA, UK, France, Italy and Japan.

Boehringer Ingelheim GmbH: Transforming the terminal cancer patient

Boehringer Ingelheim GmbH and Hall and Partners

Time for a re-think about terminal cancer

With the huge steps in treatment that have been made in recent years, it is an extremely exciting time in cancer research.

At the same time, empowered patients have more access to information on cancer treatments and care. They have new aspirations and expectations.

Nowadays, optimal cancer care encompasses the mind, body, spirit and emotions. Today's patient wants to take control and be an active participant in their cancer treatment.

With this backdrop, conversations about cancer within the...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands